The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality
DR Youlden, SM Cramb, NAM Dunn, JM Muller… - Cancer …, 2012 - Elsevier
BACKGROUND: This paper presents the latest international descriptive epidemiological
data for invasive breast cancer amongst women, including incidence, survival and mortality …
data for invasive breast cancer amongst women, including incidence, survival and mortality …
Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis
SM Hashemi, H Rafiemanesh, T Aghamohammadi… - Breast Cancer, 2020 - Springer
This study aimed to determine the prevalence of anxiety among breast cancer patients. In
April 2019, three electronic databases (PubMed, Web of Science, and Scopus) were …
April 2019, three electronic databases (PubMed, Web of Science, and Scopus) were …
Technologies for global health
Executive summary Availability of health technology is inversely related to health need.
Although health-care systems in high-income countries make extensive use of technology …
Although health-care systems in high-income countries make extensive use of technology …
Epidemiology of breast cancer in women
SS Coughlin - Breast Cancer Metastasis and Drug Resistance …, 2019 - Springer
Epidemiologic studies have contributed importantly to current knowledge of environmental
and genetic risk factors for breast cancer. Worldwide, breast cancer is an important cause of …
and genetic risk factors for breast cancer. Worldwide, breast cancer is an important cause of …
Natural products for the management and prevention of breast cancer
Among all types of cancer, breast cancer is one of the most challenging diseases, which is
responsible for a large number of cancer related deaths. Hormonal therapy, surgery …
responsible for a large number of cancer related deaths. Hormonal therapy, surgery …
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer
J O'Shaughnessy, L Schwartzberg… - Journal of clinical …, 2014 - ascopubs.org
Purpose There is a lack of treatments providing survival benefit for patients with metastatic
triple-negative breast cancer (mTNBC), with no standard of care. A randomized phase II trial …
triple-negative breast cancer (mTNBC), with no standard of care. A randomized phase II trial …
Trastuzumab in the treatment of breast cancer
S Maximiano, P Magalhaes, MP Guerreiro, M Morgado - BioDrugs, 2016 - Springer
Breast cancer (BC) is the most common cancer in women worldwide, and has an
undeniable negative impact on public health. The advent of molecular biology and …
undeniable negative impact on public health. The advent of molecular biology and …
[HTML][HTML] Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents
Triple-negative breast cancer (TNBC) is an aggressive histological subtype with limited
treatment options and very poor prognosis following progression after standard …
treatment options and very poor prognosis following progression after standard …
Immune tumor microenvironment in breast cancer and the participation of estrogen and its receptors in cancer physiopathology
Breast cancer is characterized by cellular and molecular heterogeneity. Several molecular
events are involved in controlling malignant cell processes. In this sense, there is an …
events are involved in controlling malignant cell processes. In this sense, there is an …
Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25
L Zan, Q Chen, L Zhang, X Li - Bioengineered, 2019 - Taylor & Francis
The aim of the present study was to investigate the anticancer effects and potential
mechanisms of polyphenol epigallocatechin-3-gallate (EGCG) on breast cancer MCF-7 cells …
mechanisms of polyphenol epigallocatechin-3-gallate (EGCG) on breast cancer MCF-7 cells …